Clinical Trials Insight: 700052515

Trial Profile

Clinical Trials Insight: 700052515

Phase of Trial: Phase I

Latest Information Update: 27 Oct 2010

At a glance

  • Drugs IPI 940 (Primary)
  • Indications Inflammatory pain; Neuropathic pain
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Oct 2010 Results were reported in an Infinity media release.
    • 27 Oct 2010 Status changed from planning to completed according to results reported in an Infinity media release.
    • 13 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top